The Home Visiting Research, Improvement, Sustainability and Evaluation Center (HV-RISE)
Forecast
Health Resources and Services Administration plans to offer grants of up to $5.0 million (at least $5.0 million) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make one award worth $5.0 million in total. It is a forecast: the notice is expected around November 17, 2026, with applications due around February 23, 2027.
From the official notice on Grants.gov, last changed August 10, 2026. Checked October 31, 2026.
- Award ceiling$5.0 million
- Award floor$5.0 million
- Expected awards1
- Total funding$5.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | August 10, 2026 |
|---|---|
| Expected posting | November 17, 2026 |
| Expected deadline | February 23, 2027 |
| Expected award date | July 2, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
"Domestic" means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Home Visiting Research, Improvement, Sustainability and Evaluation (HV-RISE) Center will improve the quality of home visiting services and outcomes for families by helping home visiting programs use research to improve practice, test small scale improvements, and expand what works.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to HV-RISE Program, HomeVisiting@hrsa.gov, 301-443-2170.
Questions people ask
Who can apply for The Home Visiting Research, Improvement, Sustainability and Evaluation Center (HV-RISE)?
Health Resources and Services Administration accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for The Home Visiting Research, Improvement, Sustainability and Evaluation Center (HV-RISE)?
Expected deadline February 23, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $5.0 million each. About $5.0 million in total for one award.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience